AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The CDCCs are strategically positioned in regions identified as high-impact areas
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023
Prateek has more than 23 years of rich experience in Human Resource
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
The entire integration and transition of the brands is expected to be completed by March 2022
Subscribe To Our Newsletter & Stay Updated